Rchr
J-GLOBAL ID:201101001344553141   Update date: Jul. 16, 2024

Suzuki Shiro

Suzuki Shiro
Research theme for competitive and other funds  (6):
  • 2019 - 2022 Antitumor immune response in patients with endometrial cancer from the perspective of uterine Ecosystem
  • 2019 - 2022 Elucidation of malignancy, peritoneal dissemination and spread mechanism of ovarian cancer by interaction with peritoneal mesothelium.
  • 2017 - 2020 Interdisciplinary research on intraperitoneal cell-to-cell crosstalk focusing ovarian cancer-associated mesothelial cells
  • 2016 - 2019 Analysis of tumor-infiltrating lymphocytes in malignant gynecologic tumors for development of personalized tumor immunotherapy
  • 2012 - 2015 Immunological and clinical analysis of tumor antigen specific immunotherapy combined with chemotherapy against ovarian cancer
Show all
Papers (46):
  • Ryosuke Uekusa, Akira Yokoi, Eri Watanabe, Kosuke Yoshida, Masato Yoshihara, Satoshi Tamauchi, Yusuke Shimizu, Yoshiki Ikeda, Nobuhisa Yoshikawa, Kaoru Niimi, et al. Real-world data of poly (ADP-ribose) polymerase inhibitor response in Japanese patients with ovarian cancer. Cancer medicine. 2024. 13. 7. e7149
  • Toshiaki Yoshikawa, Zhiwen Wu, Satoshi Inoue, Hitomi Kasuya, Hirokazu Matsushita, Yusuke Takahashi, Hiroaki Kuroda, Waki Hosoda, Shiro Suzuki, Yuki Kagoya. Genetic ablation of PRDM1 in antitumor T cells enhances therapeutic efficacy of adoptive immunotherapy. Blood. 2022. 139. 14. 2156-2172
  • Mayu Ukai, Shiro Suzuki, Masato Yoshihara, Akira Yokoi, Nobuhisa Yoshikawa, Hiroaki Kajiyama, Fumitaka Kikkawa. Adjuvant taxane plus platinum chemotherapy for stage I ovarian clear cell carcinoma with complete surgical staging: are more than three cycles necessary?. International Journal of Clinical Oncology. 2021
  • Kazuto Nosaka, Shiro Suzuki, Toshiaki Yoshikawa, Manami Shimomura, Kazuhisa Kitami, Kosuke Yoshida, Masato Yoshihara, Fumitaka Kikkawa, Tetsuya Nakatsura, Hiroaki Kajiyama. Heat Shock Protein 105 as an Immunotherapeutic Target for Patients With Cervical Cancer. Anticancer research. 2021. 41. 10. 4741-4751
  • Kenichi Nakamura, Kaoru Niimi, Eiko Yamamoto, Yoshiki Ikeda, Kimihiro Nishino, Shiro Suzuki, Hiroaki Kajiyama, Fumitaka Kikkawa. Core 2 β1,6-N-acetylglucosaminyltransferases accelerate the escape of choriocarcinoma from natural killer cell immunity. Biochemistry and biophysics reports. 2021. 26. 100951-100951
more...
MISC (6):
more...
Professional career (1):
  • 博士(医学) (名古屋大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page